Join us tomorrow at 8:30 AM ET for a live call and webcast as we share our Q3 2025 results. Register here: https://lnkd.in/ejrbExcZ #JNJ #earnings

Always interesting to see how J&J continues to perform quarter over quarter. Earnings calls often reveal more than just numbers they reflect strategic priorities and market confidence. Looking forward to the insights tomorrow.

David Birchard

Founder & Lead Engineer | Crucible Virogenics | Governance‑Native Biotech | Modular Viral Platforms for Translational Medicine, Resilience Engineering, and Public Health Innovation

1w

Strong results reflect more than financial performance; they signal continuity and resilience in a sector where trust is paramount. In healthcare, sustaining innovation while reinforcing patient and institutional confidence is what ultimately defines long‑term value. Encouraged to see J&J balancing both dimensions as it looks ahead.

Xiyun Wang

Chief Marketing Officer at Tempus (NASDAQ: TEM) | Advisor to Early-Stage Tech Companies

11h

Excited to hear what J&J’s next chapter holds—strategy speaks louder than numbers! 💡

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories